Association of airway hyperresponsiveness with reduced quality of life in patients with moderate to severe asthma

Annals of Allergy, Asthma and Immunology

Volumn 98, Issue 1, 2007, Pages 44-50

  Porsbjerg, Celeste ^a   Rasmussen, Linda ^a   Nolte, Hendrik ^a   Backer, Vibeke ^a  

^a BISPEBJERG HOSPITAL   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

METHACHOLINE;

ADOLESCENT; ADULT; ARTICLE; ASTHMA; ASTHMA QUALITY OF LIFE QUESTIONNAIRE; BRONCHUS HYPERREACTIVITY; DISEASE SEVERITY; FEMALE; FORCED EXPIRATORY VOLUME; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; QUESTIONNAIRE; REGRESSION ANALYSIS;

EID: 33846199949     PISSN: 10811206     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1081-1206(10)60858-7     Document Type: Article

References (30)

1. Sont JK, van Krieken JHJM, Evertse CE, Hooijer R, Willems LNA, Sterk PJ. The relationship between the inflammatory infiltrate in bronchial biopsies and clinical severity of asthma in patients treated with inhaled steroids. Thorax. 1996;51: 496-502.
2. Boulet LP, Turcotte H, Brochu A. Persistence of airway obstruction and hyperresponsiveness in subjects with asthma remission. Chem. 1994;105:1024-1031.
3. in't Veen JC, Smits HH, Hiemstra PS, Zwinderman AE, Sterk PJ, Bel EH. Lung function and sputum characteristics of patients with severe asthma during an induced exacerbation by double-blind steroid withdrawal. Am J Respir Crit Care Med. 1999;160:93-99.
4. Dahl R, Larsen BB, Venge P. Effect of long-term treatment with inhaled budesonide or theophylline on lung function, airway reactivity and asthma symptoms. Respir Med. 2002;96: 432-438.
5. Sont JK, Willems LN, Bel EH, van Krieken JH, Vandenbroucke JP, Sterk PJ; The AMPUL Study Group. Clinical control and histopathologic outcome of asthma when using airway hyperresponsiveness as an additional guide to long-term treatment. Am J Respir Crit Care Med. 1999;159(4 pt 1):1043-51.
6. Juniper EF, Guyatt GH, Epstein RS, Ferrie PJ, Jaeschke R, Hiller TK. Evaluation of impairment of health related quality of life in asthma: development of a questionnaire for use in clinical trials. Thorax. 1992;47:76-83.
7. Juniper EF, Wisniewski ME, Cox FM, Emmett AH, Nielsen KE, O'Byrne PM. Relationship between quality of life and clinical status in asthma: a factor analysis. Eur Respir J. 2004;23:287-291.
8. Moy ML, Israel E, Weiss ST, Juniper EF, Dube L, Drazen JM; NHBLI Asthma Clinical Research Network. Clinical predictors of health-related quality of life depend on asthma severity. Am J Respir Crit Care Med 2001;163:924-929.
9. Ricconi G, D'Orazio N, Di Ilio C, et al. Bronchial hyperresponsiveness and quality of life in asthmatics. Respiration. 2003;70: 496-499.
10. Cockcroft DW, Killian DN, Mellon JJ, Hargreave FE. Bronchial reactivity to inhaled histamine: a method and clinical survey. Clin Allergy. 1977;7:235-243.
11. Woolcock AJ, Peat JK, Salome CM, et al. Prevalence of bronchial hyperresponsiveness and asthma in a rural adult population. Thorax. 1987;42:361-368.
12. Crapo RO, Casaburi R, Coates AL, et al. Guidelines for methacholine and exercise challenge testing-1999. This official statement of the American Thoracic Society was adopted by the ATS Board of Directors, July 1999. Am J Respir Crit Care Med. 2000;161:309-329.
13. Rasmussen LM, Phanareth K, Nolte H, Backer V. Internet-based monitoring of asthma: a long-term, randomized clinical study of 300 asthmatic subjects. J Allergy Clin Immunol. 2005;115:1137-1142.
14. Nolte H, Nepper-Christensen S, Backer V. Unawareness and undertreatment of asthma and rhinitis in general practice. Respir Med. 2006;100:354-362.
15. Porsbjerg C, Rasmussen L, Nepper-Christensen SC, Harmsen L, Nolte H, Backer V. Airway hyperresponsiveness to methacholine and quality of life. In: Program and abstracts of the European Respiratory Society Annual Meeting; Copenhagen: September 17-21, 2005.
16. Winder JA, Nash K, Brunn JW. Validation of a life quality (LQ) test for asthma. Ann Allergy Asthma Immunol. 2000;85(6 pt l):467-72.
17. Global Initiative for Asthma (GINA). Global Strategy for Asthma Management and Prevention: NHLBI/WHO Workshop Report. Bethesda, MD: National Institutes of Health, National Heath Lung and Blood Institute; 1995. NIH publication 95: 3659.
18. Juniper EF, Buist AS, Cox FM, Ferrie PJ, King DR. Validation of a standardized version of the Asthma Quality of Life Questionnaire. Chest. 1999;115:1265-1270.
19. Juniper EF, Guyatt GH, Willan A, Griffith LE. Determining a minimal important change in a disease-specific Quality of Life Questionnaire. J Clin Epidemiol. 1994;47(1):81-87.
20. Yan K, Salome C, Woolcock AJ. Rapid method for measurement of bronchial responsiveness. Thorax. 1983;38:760-765.
21. Standardization of Spirometry, 1994 Update. American Thoracic Society. Am J Respir Crit Care Med. 1995 Sep;152(3):1107-1136.
22. Reddel HK, Salome C, Woolcock A. Which index of peak expiratory flow is most useful in the management of stable asthma? Am J Respir Crit Care Med. 1995;151:1320-1325.
23. Dreborg S. Skin test used in type I allergy testing (position paper). Allergy 1989;44(suppl. 10):22-30.
24. Ward C, Pais M, Bish R, Reid D, Feltis B, Johns D, Walters EH. Airway inflammation, basement membrane thickening and bronchial hyperresponsiveness in asthma. Thorax. 2002;57: 309-316.
25. Laprise C, Laviolette M, Boutet M, Boulet LP. Asymptomatic airway hyperresponsiveness: relationships with airway inflammation and remodelling. Eur Respir J. 1999;14:63-73.
26. Roberts G, Mylonopoulou M, Hurley C, Lack G. Impairment in quality of life is directly related to the level of allergen exposure and allergic airway inflammation. Clin Exp Allergy. 2005;35: 1295-1300.
27. Bousquet J. Global initiative for asthma (GINA) and its objectives. Clin Exp Allergy. 2000;30(suppl 1):2-5.
28. Cirillo I, Vizzaccaro A, Klersy C, et al. Quality of life and polysensitization in young men with intermittent asthma. Ann Allergy Asthma Immunol. 2005;94:640-643.
29. O'Byrne PM, Inman MD. Airway hyperresponsiveness. Chest. 2003;123(3 suppl):411S-416S.
30. Xuan W, Marks GB, Toelle BG, et al. Risk factors for onset and remission of atopy, wheeze, and airway hyperresponsiveness. Thorax. 2002;57:104-109.